|
|
Article: Hormone replacement therapy is questionable in breast cancer survivors.
- Article from:
- OBGYN & Reproduction Week
- Article date:
- March 24, 2003
CopyrightCOPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2003 MAR 24 - (NewsRx.com & NewsRx.net) -- Hormone replacement therapy is questionable in breast cancer survivors.
According to a study from Finland, "Health care professionals in modern Western societies will meet an increasing number of women surviving breast cancer. How the menopause of these women should be treated is still an open question. Use of hormone replacement therapy (HRT) may, at least in theory, increase the risk for recurrence of cancer, but its categoric refusal is a double edged sword because it also denies these women all the undisputable health benefits HRT provides.
"This refusal is not, supported by the observational data ...